2023-2029 Global Human Pain Management Drug Industry Research & Trends Analysis Report
2023-2029 Global Human Pain Management Drug Industry Research & Trends Analysis Report
Analysis of the Human Pain Management Drug Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the research report published by Market IntelliX, the global market for Human Pain Management Drug should grow from US$ 72000 million in 2022 to US$ 96030 million by 2029, with a CAGR of 4.2% for the period of 2023-2029.
China Human Pain Management Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Human Pain Management Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, OTC segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Human Pain Management Drug include AbbVie Inc. (Allergan plc), Bristol Myers Squibb Co., Sanofi S.A., Boehringer Ingelheim International GmbH, Pfizer Inc., Zydus Lifesciences Ltd. (Cadila Pharmaceuticals), GSK plc., Abbott Laboratories, Inc. and Novartis AG, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Pain relievers, including acetaminophen, NSAIDs and opioids, can ease temporary aches and chronic pain.
This report aims to provide a comprehensive study of the global market for Human Pain Management Drug. Report Highlights:
(1) Global Human Pain Management Drug market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Human Pain Management Drug market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Human Pain Management Drug market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Human Pain Management Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Human Pain Management Drug segment by type and by application and regional segment by type and by application.
(6) Human Pain Management Drug industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
OTC
Rx
Market segment by application, can be divided into
Hospital
Retail Pharmacy
Other
Market segment by players, this report covers
AbbVie Inc. (Allergan plc)
Bristol Myers Squibb Co.
Sanofi S.A.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
GSK plc.
Abbott Laboratories, Inc.
Novartis AG
Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc.
Bayer AG
F. Hoffmann-La Roche Ltd.
Procter & Gamble
AstraZeneca
Cardinal Health
Perrigo Company Plc.
Bausch Health Companies Inc.
Viatris
Amneal Pharmaceuticals
Purdue Pharmaceuticals L.P.
1 Market Overview
1.1 Product Overview and Scope of Human Pain Management Drug
1.2 Global Human Pain Management Drug Market Size and Forecast
1.3 China Human Pain Management Drug Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Human Pain Management Drug Share in Global Market, 2018-2029
1.4.2 Human Pain Management Drug Market Size: China VS Global, 2018-2029
1.5 Human Pain Management Drug Market Dynamics
1.5.1 Human Pain Management Drug Market Drivers
1.5.2 Human Pain Management Drug Market Restraints
1.5.3 Human Pain Management Drug Industry Trends
1.5.4 Human Pain Management Drug Industry Policy
2 Global Competitive Situation by Company
2.1 Global Human Pain Management Drug Revenue by Company (2018-2023)
2.2 Global Human Pain Management Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Human Pain Management Drug Concentration Ratio
2.4 Global Human Pain Management Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Human Pain Management Drug Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Human Pain Management Drug Revenue by Company (2018-2023)
3.2 China Human Pain Management Drug Human Pain Management Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Human Pain Management Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Human Pain Management Drug Industry Chain
4.2 Human Pain Management Drug Upstream Analysis
4.3 Human Pain Management Drug Midstream Analysis
4.4 Human Pain Management Drug Downstream Analysis
5 Sights by Type
5.1 Human Pain Management Drug Classification
5.1.1 OTC
5.1.2 Rx
5.2 By Type, Global Human Pain Management Drug Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Human Pain Management Drug Revenue, 2018-2029
6 Sights by Application
6.1 Human Pain Management Drug Segment by Application
6.1.1 Hospital
6.1.2 Retail Pharmacy
6.1.3 Other
6.2 By Application, Global Human Pain Management Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Human Pain Management Drug Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Human Pain Management Drug Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Human Pain Management Drug Market Size, 2018-2029
7.3 North America
7.3.1 North America Human Pain Management Drug Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Human Pain Management Drug Market Size Market Share
7.4 Europe
7.4.1 Europe Human Pain Management Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Human Pain Management Drug Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Human Pain Management Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Human Pain Management Drug Market Size Market Share
7.6 South America
7.6.1 South America Human Pain Management Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Human Pain Management Drug Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Human Pain Management Drug Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Human Pain Management Drug Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Human Pain Management Drug Market Size, 2018-2029
8.3.2 By Company, U.S. Human Pain Management Drug Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Human Pain Management Drug Market Size, 2018-2029
8.4.2 By Company, Europe Human Pain Management Drug Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Human Pain Management Drug Market Size, 2018-2029
8.5.2 By Company, China Human Pain Management Drug Revenue Market Share, 2018-2023
8.5.3 By Type, China Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Human Pain Management Drug Market Size, 2018-2029
8.6.2 By Company, Japan Human Pain Management Drug Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Human Pain Management Drug Market Size, 2018-2029
8.7.2 By Company, South Korea Human Pain Management Drug Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Human Pain Management Drug Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Human Pain Management Drug Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Human Pain Management Drug Market Size, 2018-2029
8.9.2 By Company, India Human Pain Management Drug Revenue Market Share, 2018-2023
8.9.3 By Type, India Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Human Pain Management Drug Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Human Pain Management Drug Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 AbbVie Inc. (Allergan plc)
9.1.1 AbbVie Inc. (Allergan plc) Company Information, Head Office, Market Area and Industry Position
9.1.2 AbbVie Inc. (Allergan plc) Company Profile and Main Business
9.1.3 AbbVie Inc. (Allergan plc) Human Pain Management Drug Models, Specifications and Application
9.1.4 AbbVie Inc. (Allergan plc) Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.1.5 AbbVie Inc. (Allergan plc) Recent Developments
9.2 Bristol Myers Squibb Co.
9.2.1 Bristol Myers Squibb Co. Company Information, Head Office, Market Area and Industry Position
9.2.2 Bristol Myers Squibb Co. Company Profile and Main Business
9.2.3 Bristol Myers Squibb Co. Human Pain Management Drug Models, Specifications and Application
9.2.4 Bristol Myers Squibb Co. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.2.5 Bristol Myers Squibb Co. Recent Developments
9.3 Sanofi S.A.
9.3.1 Sanofi S.A. Company Information, Head Office, Market Area and Industry Position
9.3.2 Sanofi S.A. Company Profile and Main Business
9.3.3 Sanofi S.A. Human Pain Management Drug Models, Specifications and Application
9.3.4 Sanofi S.A. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.3.5 Sanofi S.A. Recent Developments
9.4 Boehringer Ingelheim International GmbH
9.4.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
9.4.2 Boehringer Ingelheim International GmbH Company Profile and Main Business
9.4.3 Boehringer Ingelheim International GmbH Human Pain Management Drug Models, Specifications and Application
9.4.4 Boehringer Ingelheim International GmbH Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.4.5 Boehringer Ingelheim International GmbH Recent Developments
9.5 Pfizer Inc.
9.5.1 Pfizer Inc. Company Information, Head Office, Market Area and Industry Position
9.5.2 Pfizer Inc. Company Profile and Main Business
9.5.3 Pfizer Inc. Human Pain Management Drug Models, Specifications and Application
9.5.4 Pfizer Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.5.5 Pfizer Inc. Recent Developments
9.6 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
9.6.1 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Information, Head Office, Market Area and Industry Position
9.6.2 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Profile and Main Business
9.6.3 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Models, Specifications and Application
9.6.4 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.6.5 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Developments
9.7 GSK plc.
9.7.1 GSK plc. Company Information, Head Office, Market Area and Industry Position
9.7.2 GSK plc. Company Profile and Main Business
9.7.3 GSK plc. Human Pain Management Drug Models, Specifications and Application
9.7.4 GSK plc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.7.5 GSK plc. Recent Developments
9.8 Abbott Laboratories, Inc.
9.8.1 Abbott Laboratories, Inc. Company Information, Head Office, Market Area and Industry Position
9.8.2 Abbott Laboratories, Inc. Company Profile and Main Business
9.8.3 Abbott Laboratories, Inc. Human Pain Management Drug Models, Specifications and Application
9.8.4 Abbott Laboratories, Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.8.5 Abbott Laboratories, Inc. Recent Developments
9.9 Novartis AG
9.9.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
9.9.2 Novartis AG Company Profile and Main Business
9.9.3 Novartis AG Human Pain Management Drug Models, Specifications and Application
9.9.4 Novartis AG Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.9.5 Novartis AG Recent Developments
9.10 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
9.10.1 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Information, Head Office, Market Area and Industry Position
9.10.2 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Profile and Main Business
9.10.3 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Models, Specifications and Application
9.10.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.10.5 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Developments
9.11 Sun Pharmaceutical Industries Ltd.
9.11.1 Sun Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
9.11.2 Sun Pharmaceutical Industries Ltd. Company Profile and Main Business
9.11.3 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Models, Specifications and Application
9.11.4 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.11.5 Sun Pharmaceutical Industries Ltd. Recent Developments
9.12 Teva Pharmaceuticals Ltd.
9.12.1 Teva Pharmaceuticals Ltd. Company Information, Head Office, Market Area and Industry Position
9.12.2 Teva Pharmaceuticals Ltd. Company Profile and Main Business
9.12.3 Teva Pharmaceuticals Ltd. Human Pain Management Drug Models, Specifications and Application
9.12.4 Teva Pharmaceuticals Ltd. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.12.5 Teva Pharmaceuticals Ltd. Recent Developments
9.13 Mallinckrodt Pharmaceuticals
9.13.1 Mallinckrodt Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.13.2 Mallinckrodt Pharmaceuticals Company Profile and Main Business
9.13.3 Mallinckrodt Pharmaceuticals Human Pain Management Drug Models, Specifications and Application
9.13.4 Mallinckrodt Pharmaceuticals Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.13.5 Mallinckrodt Pharmaceuticals Recent Developments
9.14 Endo Pharmaceuticals Inc.
9.14.1 Endo Pharmaceuticals Inc. Company Information, Head Office, Market Area and Industry Position
9.14.2 Endo Pharmaceuticals Inc. Company Profile and Main Business
9.14.3 Endo Pharmaceuticals Inc. Human Pain Management Drug Models, Specifications and Application
9.14.4 Endo Pharmaceuticals Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.14.5 Endo Pharmaceuticals Inc. Recent Developments
9.15 Bayer AG
9.15.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
9.15.2 Bayer AG Company Profile and Main Business
9.15.3 Bayer AG Human Pain Management Drug Models, Specifications and Application
9.15.4 Bayer AG Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.15.5 Bayer AG Recent Developments
9.16 F. Hoffmann-La Roche Ltd.
9.16.1 F. Hoffmann-La Roche Ltd. Company Information, Head Office, Market Area and Industry Position
9.16.2 F. Hoffmann-La Roche Ltd. Company Profile and Main Business
9.16.3 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Models, Specifications and Application
9.16.4 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.16.5 F. Hoffmann-La Roche Ltd. Recent Developments
9.17 Procter & Gamble
9.17.1 Procter & Gamble Company Information, Head Office, Market Area and Industry Position
9.17.2 Procter & Gamble Company Profile and Main Business
9.17.3 Procter & Gamble Human Pain Management Drug Models, Specifications and Application
9.17.4 Procter & Gamble Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.17.5 Procter & Gamble Recent Developments
9.18 AstraZeneca
9.18.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
9.18.2 AstraZeneca Company Profile and Main Business
9.18.3 AstraZeneca Human Pain Management Drug Models, Specifications and Application
9.18.4 AstraZeneca Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.18.5 AstraZeneca Recent Developments
9.19 Cardinal Health
9.19.1 Cardinal Health Company Information, Head Office, Market Area and Industry Position
9.19.2 Cardinal Health Company Profile and Main Business
9.19.3 Cardinal Health Human Pain Management Drug Models, Specifications and Application
9.19.4 Cardinal Health Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.19.5 Cardinal Health Recent Developments
9.20 Perrigo Company Plc.
9.20.1 Perrigo Company Plc. Company Information, Head Office, Market Area and Industry Position
9.20.2 Perrigo Company Plc. Company Profile and Main Business
9.20.3 Perrigo Company Plc. Human Pain Management Drug Models, Specifications and Application
9.20.4 Perrigo Company Plc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.20.5 Perrigo Company Plc. Recent Developments
9.21 Bausch Health Companies Inc.
9.21.1 Bausch Health Companies Inc. Company Information, Head Office, Market Area and Industry Position
9.21.2 Bausch Health Companies Inc. Company Profile and Main Business
9.21.3 Bausch Health Companies Inc. Human Pain Management Drug Models, Specifications and Application
9.21.4 Bausch Health Companies Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.21.5 Bausch Health Companies Inc. Recent Developments
9.22 Viatris
9.22.1 Viatris Company Information, Head Office, Market Area and Industry Position
9.22.2 Viatris Company Profile and Main Business
9.22.3 Viatris Human Pain Management Drug Models, Specifications and Application
9.22.4 Viatris Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.22.5 Viatris Recent Developments
9.23 Amneal Pharmaceuticals
9.23.1 Amneal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.23.2 Amneal Pharmaceuticals Company Profile and Main Business
9.23.3 Amneal Pharmaceuticals Human Pain Management Drug Models, Specifications and Application
9.23.4 Amneal Pharmaceuticals Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.23.5 Amneal Pharmaceuticals Recent Developments
9.24 Purdue Pharmaceuticals L.P.
9.24.1 Purdue Pharmaceuticals L.P. Company Information, Head Office, Market Area and Industry Position
9.24.2 Purdue Pharmaceuticals L.P. Company Profile and Main Business
9.24.3 Purdue Pharmaceuticals L.P. Human Pain Management Drug Models, Specifications and Application
9.24.4 Purdue Pharmaceuticals L.P. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
9.24.5 Purdue Pharmaceuticals L.P. Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Human Pain Management Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Human Pain Management Drug Market Restraints
Table 3. Human Pain Management Drug Market Trends
Table 4. Human Pain Management Drug Industry Policy
Table 5. Global Human Pain Management Drug Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Human Pain Management Drug Revenue Market Share by Company (2018-2023)
Table 7. Global Human Pain Management Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Human Pain Management Drug Mergers & Acquisitions, Expansion Plans
Table 9. Global Human Pain Management Drug Manufacturers Product Type
Table 10. China Human Pain Management Drug Revenue by Company (2018-2023) & (US$ million)
Table 11. China Human Pain Management Drug Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Human Pain Management Drug Upstream (Raw Materials)
Table 13. Global Human Pain Management Drug Typical Customers
Table 14. Human Pain Management Drug Typical Distributors
Table 15. By Type, Global Human Pain Management Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Human Pain Management Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Human Pain Management Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Human Pain Management Drug Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Human Pain Management Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Human Pain Management Drug Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Human Pain Management Drug Revenue Market Share, 2018-2029
Table 22. AbbVie Inc. (Allergan plc) Company Information, Head Office, Market Area and Industry Position
Table 23. AbbVie Inc. (Allergan plc) Company Profile and Main Business
Table 24. AbbVie Inc. (Allergan plc) Human Pain Management Drug Models, Specifications and Application
Table 25. AbbVie Inc. (Allergan plc) Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 26. AbbVie Inc. (Allergan plc) Recent Developments
Table 27. Bristol Myers Squibb Co. Company Information, Head Office, Market Area and Industry Position
Table 28. Bristol Myers Squibb Co. Company Profile and Main Business
Table 29. Bristol Myers Squibb Co. Human Pain Management Drug Models, Specifications and Application
Table 30. Bristol Myers Squibb Co. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 31. Bristol Myers Squibb Co. Recent Developments
Table 32. Sanofi S.A. Company Information, Head Office, Market Area and Industry Position
Table 33. Sanofi S.A. Company Profile and Main Business
Table 34. Sanofi S.A. Human Pain Management Drug Models, Specifications and Application
Table 35. Sanofi S.A. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 36. Sanofi S.A. Recent Developments
Table 37. Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
Table 38. Boehringer Ingelheim International GmbH Company Profile and Main Business
Table 39. Boehringer Ingelheim International GmbH Human Pain Management Drug Models, Specifications and Application
Table 40. Boehringer Ingelheim International GmbH Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 41. Boehringer Ingelheim International GmbH Recent Developments
Table 42. Pfizer Inc. Company Information, Head Office, Market Area and Industry Position
Table 43. Pfizer Inc. Company Profile and Main Business
Table 44. Pfizer Inc. Human Pain Management Drug Models, Specifications and Application
Table 45. Pfizer Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 46. Pfizer Inc. Recent Developments
Table 47. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Information, Head Office, Market Area and Industry Position
Table 48. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Profile and Main Business
Table 49. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Models, Specifications and Application
Table 50. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 51. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Developments
Table 52. GSK plc. Company Information, Head Office, Market Area and Industry Position
Table 53. GSK plc. Company Profile and Main Business
Table 54. GSK plc. Human Pain Management Drug Models, Specifications and Application
Table 55. GSK plc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 56. GSK plc. Recent Developments
Table 57. Abbott Laboratories, Inc. Company Information, Head Office, Market Area and Industry Position
Table 58. Abbott Laboratories, Inc. Company Profile and Main Business
Table 59. Abbott Laboratories, Inc. Human Pain Management Drug Models, Specifications and Application
Table 60. Abbott Laboratories, Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 61. Abbott Laboratories, Inc. Recent Developments
Table 62. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 63. Novartis AG Company Profile and Main Business
Table 64. Novartis AG Human Pain Management Drug Models, Specifications and Application
Table 65. Novartis AG Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 66. Novartis AG Recent Developments
Table 67. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Information, Head Office, Market Area and Industry Position
Table 68. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Profile and Main Business
Table 69. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Models, Specifications and Application
Table 70. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 71. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Developments
Table 72. Sun Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
Table 73. Sun Pharmaceutical Industries Ltd. Company Profile and Main Business
Table 74. Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Models, Specifications and Application
Table 75. Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 76. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 77. Teva Pharmaceuticals Ltd. Company Information, Head Office, Market Area and Industry Position
Table 78. Teva Pharmaceuticals Ltd. Company Profile and Main Business
Table 79. Teva Pharmaceuticals Ltd. Human Pain Management Drug Models, Specifications and Application
Table 80. Teva Pharmaceuticals Ltd. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 81. Teva Pharmaceuticals Ltd. Recent Developments
Table 82. Mallinckrodt Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 83. Mallinckrodt Pharmaceuticals Company Profile and Main Business
Table 84. Mallinckrodt Pharmaceuticals Human Pain Management Drug Models, Specifications and Application
Table 85. Mallinckrodt Pharmaceuticals Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 86. Mallinckrodt Pharmaceuticals Recent Developments
Table 87. Endo Pharmaceuticals Inc. Company Information, Head Office, Market Area and Industry Position
Table 88. Endo Pharmaceuticals Inc. Company Profile and Main Business
Table 89. Endo Pharmaceuticals Inc. Human Pain Management Drug Models, Specifications and Application
Table 90. Endo Pharmaceuticals Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 91. Endo Pharmaceuticals Inc. Recent Developments
Table 92. Bayer AG Company Information, Head Office, Market Area and Industry Position
Table 93. Bayer AG Company Profile and Main Business
Table 94. Bayer AG Human Pain Management Drug Models, Specifications and Application
Table 95. Bayer AG Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 96. Bayer AG Recent Developments
Table 97. F. Hoffmann-La Roche Ltd. Company Information, Head Office, Market Area and Industry Position
Table 98. F. Hoffmann-La Roche Ltd. Company Profile and Main Business
Table 99. F. Hoffmann-La Roche Ltd. Human Pain Management Drug Models, Specifications and Application
Table 100. F. Hoffmann-La Roche Ltd. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 101. F. Hoffmann-La Roche Ltd. Recent Developments
Table 102. Procter & Gamble Company Information, Head Office, Market Area and Industry Position
Table 103. Procter & Gamble Company Profile and Main Business
Table 104. Procter & Gamble Human Pain Management Drug Models, Specifications and Application
Table 105. Procter & Gamble Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 106. Procter & Gamble Recent Developments
Table 107. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 108. AstraZeneca Company Profile and Main Business
Table 109. AstraZeneca Human Pain Management Drug Models, Specifications and Application
Table 110. AstraZeneca Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 111. AstraZeneca Recent Developments
Table 112. Cardinal Health Company Information, Head Office, Market Area and Industry Position
Table 113. Cardinal Health Company Profile and Main Business
Table 114. Cardinal Health Human Pain Management Drug Models, Specifications and Application
Table 115. Cardinal Health Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 116. Cardinal Health Recent Developments
Table 117. Perrigo Company Plc. Company Information, Head Office, Market Area and Industry Position
Table 118. Perrigo Company Plc. Company Profile and Main Business
Table 119. Perrigo Company Plc. Human Pain Management Drug Models, Specifications and Application
Table 120. Perrigo Company Plc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 121. Perrigo Company Plc. Recent Developments
Table 122. Bausch Health Companies Inc. Company Information, Head Office, Market Area and Industry Position
Table 123. Bausch Health Companies Inc. Company Profile and Main Business
Table 124. Bausch Health Companies Inc. Human Pain Management Drug Models, Specifications and Application
Table 125. Bausch Health Companies Inc. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 126. Bausch Health Companies Inc. Recent Developments
Table 127. Viatris Company Information, Head Office, Market Area and Industry Position
Table 128. Viatris Company Profile and Main Business
Table 129. Viatris Human Pain Management Drug Models, Specifications and Application
Table 130. Viatris Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 131. Viatris Recent Developments
Table 132. Amneal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 133. Amneal Pharmaceuticals Company Profile and Main Business
Table 134. Amneal Pharmaceuticals Human Pain Management Drug Models, Specifications and Application
Table 135. Amneal Pharmaceuticals Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 136. Amneal Pharmaceuticals Recent Developments
Table 137. Purdue Pharmaceuticals L.P. Company Information, Head Office, Market Area and Industry Position
Table 138. Purdue Pharmaceuticals L.P. Company Profile and Main Business
Table 139. Purdue Pharmaceuticals L.P. Human Pain Management Drug Models, Specifications and Application
Table 140. Purdue Pharmaceuticals L.P. Human Pain Management Drug Revenue and Gross Margin, 2018-2023
Table 141. Purdue Pharmaceuticals L.P. Recent Developments
List of Figure
Figure 1. Human Pain Management Drug Picture
Figure 2. Global Human Pain Management Drug Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Human Pain Management Drug Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Human Pain Management Drug Market Share of Global
Figure 5. Global Human Pain Management Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Human Pain Management Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Human Pain Management Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Human Pain Management Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Human Pain Management Drug Industry Chain
Figure 10. OTC
Figure 11. Rx
Figure 12. By Type, Global Human Pain Management Drug Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Human Pain Management Drug Revenue Market Share, 2018-2029
Figure 14. Hospital
Figure 15. Retail Pharmacy
Figure 16. Other
Figure 17. By Application, Global Human Pain Management Drug Revenue, 2018-2029, US$ Million
Figure 18. By Application, Global Human Pain Management Drug Revenue Market Share, 2018-2029
Figure 19. By Region, Global Human Pain Management Drug Revenue Market Share, 2018-2029
Figure 20. North America Human Pain Management Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 21. By Country, North America Human Pain Management Drug Revenue Market Share, 2018-2023
Figure 22. Europe Human Pain Management Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, Europe Human Pain Management Drug Revenue Market Share, 2018-2023
Figure 24. Asia Pacific Human Pain Management Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 25. By Country/Region, Asia Pacific Human Pain Management Drug Revenue Market Share, 2018-2023
Figure 26. South America Human Pain Management Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, South America Human Pain Management Drug Revenue Market Share, 2018-2023
Figure 28. Middle East & Africa Human Pain Management Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 29. U.S. Human Pain Management Drug Revenue, 2018-2029, (US$ Million)
Figure 30. By Company, U.S. Human Pain Management Drug Market Share, 2018-2023
Figure 31. By Type, U.S. Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 32. By Application, U.S. Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 33. Europe Human Pain Management Drug Revenue, 2018-2029, (US$ Million)
Figure 34. By Company, Europe Human Pain Management Drug Market Share, 2018-2023
Figure 35. By Type, Europe Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 36. By Application, Europe Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 37. China Human Pain Management Drug Revenue, 2018-2029, (US$ Million)
Figure 38. By Company, China Human Pain Management Drug Market Share, 2018-2023
Figure 39. By Type, China Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 40. By Application, China Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 41. Japan Human Pain Management Drug Revenue, 2018-2029, (US$ Million)
Figure 42. By Company, Japan Human Pain Management Drug Market Share, 2018-2023
Figure 43. By Type, Japan Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 44. By Application, Japan Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 45. South Korea Human Pain Management Drug Revenue, 2018-2029, (US$ Million)
Figure 46. By Company, South Korea Human Pain Management Drug Market Share, 2018-2023
Figure 47. By Type, South Korea Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 48. By Application, South Korea Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 49. Southeast Asia Human Pain Management Drug Revenue, 2018-2029, (US$ Million)
Figure 50. By Company, Southeast Asia Human Pain Management Drug Market Share, 2018-2023
Figure 51. By Type, Southeast Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 52. By Application, Southeast Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 53. India Human Pain Management Drug Revenue, 2018-2029, (US$ Million)
Figure 54. By Company, India Human Pain Management Drug Market Share, 2018-2023
Figure 55. By Type, India Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 56. By Application, India Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 57. Middle East & Asia Human Pain Management Drug Revenue, 2018-2029, (US$ Million)
Figure 58. By Company, Middle East & Asia Human Pain Management Drug Market Share, 2018-2023
Figure 59. By Type, Middle East & Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 60. By Application, Middle East & Asia Human Pain Management Drug Revenue Market Share, 2022 VS 2029
Figure 61. Research Methodology
Figure 62. Breakdown of Primary Interviews
Figure 63. Bottom-up Approaches
Figure 64. Top-down Approaches
Research Methodology:
Human Pain Management Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|